Key Points
- Esteban Lopez, a director at Addus HomeCare, sold 166 shares on December 5 at an average price of $112.78 for $18,721.48, reducing his stake by 4.13% to 3,850 shares valued at about $434,203.
- Addus beat expectations in its latest quarter with $1.56 EPS versus $1.53 expected and revenue of $362.3 million, a 25% year-over-year increase.
- The company has a market cap of about $2.05 billion, institutional ownership of 95.35%, and a consensus analyst rating of "Moderate Buy" with an average price target of $137.11 while the stock trades near $111–116.
Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) Director Esteban Lopez sold 166 shares of the business's stock in a transaction on Friday, December 5th. The shares were sold at an average price of $112.78, for a total transaction of $18,721.48. Following the completion of the sale, the director directly owned 3,850 shares of the company's stock, valued at approximately $434,203. This trade represents a 4.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Addus HomeCare Price Performance
ADUS stock opened at $111.09 on Tuesday. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.14. The company has a market capitalization of $2.05 billion, a P/E ratio of 23.79, a PEG ratio of 1.52 and a beta of 0.94. The business has a 50 day simple moving average of $115.92 and a 200-day simple moving average of $113.79. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $136.72.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, November 3rd. The company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.53 by $0.03. Addus HomeCare had a return on equity of 9.53% and a net margin of 6.36%.The firm had revenue of $362.30 million during the quarter, compared to the consensus estimate of $354.48 million. During the same period in the prior year, the business earned $1.30 EPS. The firm's revenue was up 25.0% compared to the same quarter last year. As a group, equities analysts anticipate that Addus HomeCare Corporation will post 4.59 EPS for the current year.
Institutional Investors Weigh In On Addus HomeCare
Several hedge funds have recently modified their holdings of ADUS. Larson Financial Group LLC raised its position in shares of Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company's stock worth $28,000 after buying an additional 136 shares during the period. AlphaQuest LLC purchased a new stake in Addus HomeCare during the third quarter valued at about $37,000. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in Addus HomeCare during the first quarter worth about $41,000. Wexford Capital LP purchased a new position in shares of Addus HomeCare in the 3rd quarter worth about $41,000. Finally, State of Wyoming acquired a new position in shares of Addus HomeCare in the 2nd quarter valued at about $47,000. 95.35% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on ADUS shares. Stephens reiterated an "overweight" rating and set a $140.00 price target on shares of Addus HomeCare in a research report on Wednesday, September 3rd. Cowen reissued a "buy" rating on shares of Addus HomeCare in a report on Wednesday, November 5th. Royal Bank Of Canada lifted their price target on Addus HomeCare from $134.00 to $139.00 and gave the stock an "outperform" rating in a research note on Friday, November 7th. Weiss Ratings reiterated a "hold (c+)" rating on shares of Addus HomeCare in a research report on Wednesday, October 8th. Finally, Barclays raised their target price on shares of Addus HomeCare from $111.00 to $117.00 and gave the company an "underweight" rating in a report on Tuesday, November 4th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $137.11.
View Our Latest Stock Analysis on ADUS
Addus HomeCare Company Profile
(
Get Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
